Imago BioSciences

0 followers


Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor

Employees

51-200

Links


Org chart

Collapse
Michael Arenberg
Chief Operating & Business Officer
Wan-Jen Hong
Chief Medical Officer
Allison Anderson, MAS
Head of People & Talent
Amy Tapper
Chief Technology Officer
Cassandra Celatka
Exec. Director, Drug Discovery and Development
Maria Kleppe
Senior Director, Scientific Discovery
Stephanie Roland
Vice President Regulatory Affairs

Board & advisors

Dina Chaya
Director
Laurie Keating
Independent Director